Hypertriglyceridemia: lipoprotein receptors and atherosclerosis
- PMID: 4036704
- DOI: 10.1007/978-1-4613-2459-1_5
Hypertriglyceridemia: lipoprotein receptors and atherosclerosis
Abstract
We have shown first, that apoB mediates the binding of small VLDL Sf 20-60 and IDL, as well as LDL, to the LDL receptor. Second, apoE of an appropriate, accessible conformation is required for the binding of large VLDL to the LDL receptor; HTG-VLDL Sf greater than 60 but not normal VLDL Sf greater than 60 have this apoE population. Third, the same population of apoE that mediates binding of HTG-VLDL Sf greater than 60 to the LDL receptor modulates its binding to the beta-VLDL receptor, but it is not required for the latter interaction. Fourth, a domain of processed apoB or apoB-48 in association with a domain of the inaccessible apoE is required for binding to and uptake by the beta-VLDL receptor. Fifth, our observations suggest that the abnormal catabolism of VLDL that occurs in hypertriglyceridemia may be explained by the abnormal uptake of HTG-VLDL by either the LDL or the beta-VLDL receptor pathway. Finally, we suggest that plasma proteases may route apoB/E-containing lipoproteins to macrophages for disposal, and this results in foam cell formation.
Similar articles
-
Low-density lipoprotein receptor binding determinants switch from apolipoprotein E to apolipoprotein B during conversion of hypertriglyceridemic very-low-density lipoprotein to low-density lipoproteins.J Biol Chem. 1984 Dec 10;259(23):14728-35. J Biol Chem. 1984. PMID: 6501314
-
ApoE is necessary and sufficient for the binding of large triglyceride-rich lipoproteins to the LDL receptor; apoB is unnecessary.J Lipid Res. 1986 Jan;27(1):40-8. J Lipid Res. 1986. PMID: 3958613
-
Interactions of triglyceride-rich lipoproteins with receptors: modulation by thrombin.Semin Thromb Hemost. 1986 Oct;12(4):277-9. doi: 10.1055/s-2007-1003566. Semin Thromb Hemost. 1986. PMID: 3787267
-
Expression of LDL receptor binding determinants in very low density lipoproteins.Ann N Y Acad Sci. 1985;454:239-47. doi: 10.1111/j.1749-6632.1985.tb11863.x. Ann N Y Acad Sci. 1985. PMID: 3907464 Review.
-
Lipoprotein abnormalities in hypertriglyceridemia: significance in atherosclerosis.Am Heart J. 1987 Feb;113(2 Pt 2):555-61. doi: 10.1016/0002-8703(87)90632-6. Am Heart J. 1987. PMID: 3544770 Review. No abstract available.
Cited by
-
Distinct murine macrophage receptor pathway for human triglyceride-rich lipoproteins.J Clin Invest. 1988 Nov;82(5):1633-43. doi: 10.1172/JCI113775. J Clin Invest. 1988. PMID: 3183059 Free PMC article.
-
Complexities of plasma apolipoprotein C-III metabolism.J Lipid Res. 2011 Jun;52(6):1067-1070. doi: 10.1194/jlr.E015701. Epub 2011 Mar 18. J Lipid Res. 2011. PMID: 21421846 Free PMC article. No abstract available.
-
Metabolism of triglyceride-rich lipoproteins during alimentary lipemia.J Clin Invest. 1993 Mar;91(3):748-58. doi: 10.1172/JCI116293. J Clin Invest. 1993. PMID: 8450056 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Miscellaneous